{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:58:40Z","timestamp":1788850720604,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304382\/2020-5"],"award-info":[{"award-number":["304382\/2020-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30737-4","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T18:26:48Z","timestamp":1764440808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of local Tocilizumab administration in mitigating alveolar bone loss and inflammation in experimental periodontitis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-0742","authenticated-orcid":false,"given":"Agnes Andrade","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura Souza","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Henrique Apolin\u00e1rio","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helo\u00edsa Esp\u00ednola Sena","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Ferreira Carvalho","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Barbosa","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Addison Carvalho Xavier","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davi Neto Ara\u00fajo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rungsinee","family":"Suksakulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Q.","family":"Pirih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerly Anne Castro","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Barreto","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimundo Fernandes","family":"Ara\u00fajo J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruthineia Di\u00f3genes Alves Uch\u00f4a","family":"Lins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurigena Antunes","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"30737_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcpe.13430","volume":"48","author":"A Ravid\u00e0","year":"2021","unstructured":"Ravid\u00e0, A. et al. The influence of the interaction between staging, grading and extent on tooth loss due to periodontitis. J. Clin. Periodontol. 48, 648\u2013658. https:\/\/doi.org\/10.1111\/jcpe.13430 (2021).","journal-title":"J. Clin. Periodontol"},{"key":"30737_CR2","doi-asserted-by":"publisher","unstructured":"Shaddox, L. M., Morford, L. A. & Nibali, L. Periodontal health and disease: The contribution of genetics. Periodontol 2000 85:161\u2009\u2013\u200981. (2021). https:\/\/doi.org\/10.1111\/prd.12357","DOI":"10.1111\/prd.12357"},{"key":"30737_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41368-019-0064-z","volume":"11","author":"W Pan","year":"2019","unstructured":"Pan, W., Wang, Q. & Chen, Q. The cytokine network involved in the host immune response to periodontitis. Int. J. Oral Sci. 11, 30. https:\/\/doi.org\/10.1038\/s41368-019-0064-z (2019).","journal-title":"Int. J. Oral Sci."},{"key":"30737_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cyto.2008.10.016","volume":"45","author":"L Nibali","year":"2009","unstructured":"Nibali, L. et al. Association between periodontitis and common variants in the promoter of the interleukin-6 gene. Cytokine 45, 50\u201354. https:\/\/doi.org\/10.1016\/j.cyto.2008.10.016 (2009).","journal-title":"Cytokine"},{"key":"30737_CR5","doi-asserted-by":"publisher","unstructured":"Kang, S., Narazaki, M., Metwally, H. & Kishimoto, T. Historical overview of the interleukin-6 family cytokine. J. Exp. Med. 217 https:\/\/doi.org\/10.1084\/jem.20190347 (2020).","DOI":"10.1084\/jem.20190347"},{"key":"30737_CR6","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s11033-022-07243-1","volume":"49","author":"P-Y Chang","year":"2022","unstructured":"Chang, P-Y. et al. Interleukin-6 transiently promotes proliferation of osteoclast precursors and stimulates the production of inflammatory mediators. Mol. Biol. Rep. 49, 3927\u20133937. https:\/\/doi.org\/10.1007\/s11033-022-07243-1 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"30737_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41598-022-26421-6","volume":"13","author":"E Costantini","year":"2023","unstructured":"Costantini, E. et al. TNF\u03b1, IL-6, miR-103a-3p, miR-423-5p, miR-23a-3p, miR-15a-5p and miR-223-3p in the crevicular fluid of periodontopathic patients correlate with each other and at different stages of the disease. Sci. Rep. 13, 126. https:\/\/doi.org\/10.1038\/s41598-022-26421-6 (2023).","journal-title":"Sci. Rep."},{"issue":"S22","key":"30737_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jcpe.13245","volume":"47","author":"J Suvan","year":"2020","unstructured":"Suvan, J. et al. Subgingival instrumentation for treatment of periodontitis. A systematic review. J. Clin. Periodontol. 47 (S22), 155\u2013175. https:\/\/doi.org\/10.1111\/jcpe.13245 (2020).","journal-title":"J. Clin. Periodontol"},{"issue":"S22","key":"30737_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jcpe.13290","volume":"47","author":"M Sanz","year":"2020","unstructured":"Sanz, M. et al. Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. J. Clin. Periodontol. 47 (S22), 4\u201360. https:\/\/doi.org\/10.1111\/jcpe.13290 (2020).","journal-title":"J. Clin. Periodontol"},{"issue":"S22","key":"30737_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/jcpe.13232","volume":"47","author":"N Donos","year":"2020","unstructured":"Donos, N. et al. The adjunctive use of host modulators in non-surgical periodontal therapy. A systematic review of randomized, placebo-controlled clinical studies. J. Clin. Periodontol. 47 (S22), 199\u2013238. https:\/\/doi.org\/10.1111\/jcpe.13232 (2020).","journal-title":"J. Clin. Periodontol"},{"issue":"1","key":"30737_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40744-018-0102-x","volume":"5","author":"A Rubbert-Roth","year":"2018","unstructured":"Rubbert-Roth, A., Furst, D. E., Nebesky, J. M., Jin, A. & Berber, E. A review of recent advances using Tocilizumab in the treatment of rheumatic diseases. Rheumatol. Therapy. 5 (1), 21\u201342. https:\/\/doi.org\/10.1007\/s40744-018-0102-x (2018).","journal-title":"Rheumatol. Therapy"},{"issue":"3","key":"30737_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.yexmp.2008.03.003","volume":"84","author":"A Kato","year":"2008","unstructured":"Kato, A. et al. Early effects of Tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model. Exp. Mol. Pathol. 84 (3), 262\u2013270. https:\/\/doi.org\/10.1016\/j.yexmp.2008.03.003 (2008).","journal-title":"Exp. Mol. Pathol."},{"key":"30737_CR13","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00296-011-2021-9","volume":"32","author":"K Kanbe","year":"2012","unstructured":"Kanbe, K., Nakamura, A., Inoue, Y. & Hobo, K. Osteoprotegerin expression in bone marrow by treatment with Tocilizumab in rheumatoid arthritis. Rheumatol. Int. 32, 2669\u20132674. https:\/\/doi.org\/10.1007\/s00296-011-2021-9 (2012).","journal-title":"Rheumatol. Int."},{"key":"30737_CR14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/jcm10040878","volume":"10","author":"C Ancu\u021ba","year":"2021","unstructured":"Ancu\u021ba, C. et al. Exploring the role of Interleukin-6 receptor inhibitor Tocilizumab in patients with active rheumatoid arthritis and periodontal disease. J. Clin. Med. 10, 878. https:\/\/doi.org\/10.3390\/jcm10040878 (2021).","journal-title":"J. Clin. Med."},{"key":"30737_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/cre2.11","volume":"1","author":"T Kobayashi","year":"2015","unstructured":"Kobayashi, T. et al. Interleukin-6 receptor inhibitor Tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors. Clin. Exp. Dent. Res. 1, 63\u201373. https:\/\/doi.org\/10.1002\/cre2.11 (2015).","journal-title":"Clin. Exp. Dent. Res."},{"key":"30737_CR16","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/JPER.20-0455","volume":"92","author":"GH Apolin\u00e1rio Vieira","year":"2021","unstructured":"Apolin\u00e1rio Vieira, G. H. et al. Specific inhibition of IL-6 receptor attenuates inflammatory bone loss in experimental periodontitis. J. Periodontol. 92, 1460\u20131469. https:\/\/doi.org\/10.1002\/JPER.20-0455 (2021).","journal-title":"J. Periodontol"},{"key":"30737_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","volume":"24","author":"WN Arifin","year":"2017","unstructured":"Arifin, W. N. & Zahiruddin, W. M. Sample size calculation in animal studies using resource equation approach. Malays J. Med. Sci. 24, 101\u2013105. https:\/\/doi.org\/10.21315\/mjms2017.24.5.11 (2017).","journal-title":"Malays J. Med. Sci."},{"key":"30737_CR18","doi-asserted-by":"publisher","first-page":"e0183506","DOI":"10.1371\/journal.pone.0183506","volume":"12","author":"AA Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo, A. A. et al. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis. PLoS One. 12, e0183506. https:\/\/doi.org\/10.1371\/journal.pone.0183506 (2017).","journal-title":"PLoS One"},{"issue":"2","key":"30737_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40262-021-01092-0","volume":"61","author":"E Leung","year":"2022","unstructured":"Leung, E. et al. Pharmacokinetic\/pharmacodynamic considerations of alternate dosing strategies of Tocilizumab in COVID-19. Clin. Pharmacokinet. 61 (2), 155\u2013165. https:\/\/doi.org\/10.1007\/s40262-021-01092-0 (2022).","journal-title":"Clin. Pharmacokinet."},{"key":"30737_CR20","doi-asserted-by":"publisher","unstructured":"Silva, D. N. A. et al. Probiotic Lactobacillus rhamnosus EM1107 prevents hyperglycemia, alveolar bone loss, and inflammation in a rat model of diabetes and periodontitis. J. Periodontol. 94(3):376\u2013388. https:\/\/doi.org\/10.1002\/JPER.22-0262  (2023).","DOI":"10.1002\/JPER.22-0262"},{"key":"30737_CR21","doi-asserted-by":"publisher","first-page":"e0153716","DOI":"10.1371\/journal.pone.0153716","volume":"11","author":"CS Martins","year":"2016","unstructured":"Martins, C. S. et al. Topical HPMC\/S-Nitrosoglutathione solution decreases inflammation and bone resorption in experimental periodontal disease in rats. PLoS One. 11, e0153716. https:\/\/doi.org\/10.1371\/journal.pone.0153716 (2016).","journal-title":"PLoS One"},{"key":"30737_CR22","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1902\/jop.2005.76.6.956","volume":"76","author":"RF Leit\u00e3o","year":"2005","unstructured":"Leit\u00e3o, R. F. et al. Nitric oxide synthase Inhibition prevents alveolar bone resorption in experimental periodontitis in rats. J. Periodontol. 76, 956\u2013963. https:\/\/doi.org\/10.1902\/jop.2005.76.6.956 (2005).","journal-title":"J. Periodontol"},{"key":"30737_CR23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1476-5381.1995.tb15035.x","volume":"115","author":"B Safieh-Garabedian","year":"1995","unstructured":"Safieh-Garabedian, B., Poole, S., Allchorne, A., Winter, J. & Woolf, C. J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115, 1265\u20131275. https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb15035.x (1995).","journal-title":"Br. J. Pharmacol."},{"key":"30737_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/jrms.JRMS_524_20","volume":"26","author":"F Dastan","year":"2021","unstructured":"Dastan, F., Tabarsi, P., Abedini, A. & Saffaei, A. Tocilizumab as a promising agent against COVID-19: issues and challenges. J. Res. Med. Sci. 26, 80. https:\/\/doi.org\/10.4103\/jrms.JRMS_524_20 (2021).","journal-title":"J. Res. Med. Sci."},{"key":"30737_CR25","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","volume":"13","author":"M Sheppard","year":"2017","unstructured":"Sheppard, M., Laskou, F., Stapleton, P. P., Hadavi, S. & Dasgupta, B. Tocilizumab (Actemra). Hum. Vaccin Immunother. 13, 1972\u20131988. https:\/\/doi.org\/10.1080\/21645515.2017.1316909 (2017).","journal-title":"Hum. Vaccin Immunother"},{"key":"30737_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1902\/jop.2012.120230","volume":"84","author":"SC Trindade","year":"2013","unstructured":"Trindade, S. C. et al. Porphyromonas gingivalis HmuY-induced production of Interleukin-6 and IL-6 polymorphism in chronic periodontitis. J. Periodontol. 84, 650\u2013655. https:\/\/doi.org\/10.1902\/jop.2012.120230 (2013).","journal-title":"J. Periodontol"},{"key":"30737_CR27","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.3390\/biomedicines10102659","volume":"10","author":"R Bhuyan","year":"2022","unstructured":"Bhuyan, R. et al. Periodontitis and its inflammatory changes linked to various systemic diseases: a review of its underlying mechanisms. Biomedicines 10, 2659. https:\/\/doi.org\/10.3390\/biomedicines10102659 (2022).","journal-title":"Biomedicines"},{"key":"30737_CR28","doi-asserted-by":"publisher","first-page":"1160148","DOI":"10.3389\/fimmu.2023.1160148","volume":"14","author":"M Nolde","year":"2023","unstructured":"Nolde, M. et al. Downregulation of Interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study. Front. Immunol. 14, 1160148. https:\/\/doi.org\/10.3389\/fimmu.2023.1160148 (2023).","journal-title":"Front. Immunol."},{"key":"30737_CR29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","volume":"384","author":"IO Rosas","year":"2021","unstructured":"Rosas, I. O. et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N Engl. J. Med. 384, 1503\u20131516. https:\/\/doi.org\/10.1056\/NEJMoa2028700 (2021).","journal-title":"N Engl. J. Med."},{"key":"30737_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10787-019-00628-y","volume":"28","author":"YF Ibrahim","year":"2020","unstructured":"Ibrahim, Y. F., Moussa, R. A., Bayoumi, A. M. A. & Ahmed, A. F. Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-\u03baB\/JNK: a possible role of P-glycoprotein. Inflammopharmacology 28, 215\u2013230. https:\/\/doi.org\/10.1007\/s10787-019-00628-y (2020).","journal-title":"Inflammopharmacology"},{"key":"30737_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00774-013-0514-1","volume":"32","author":"S Kaneshiro","year":"2014","unstructured":"Kaneshiro, S. et al. IL-6 negatively regulates osteoblast differentiation through the SHP2\/MEK2 and SHP2\/Akt2 pathways in vitro. J. Bone Min. Metab. 32, 378\u2013392. https:\/\/doi.org\/10.1007\/s00774-013-0514-1 (2014).","journal-title":"J. Bone Min. Metab."},{"key":"30737_CR32","doi-asserted-by":"publisher","first-page":"41411","DOI":"10.1038\/srep41411","volume":"7","author":"W Feng","year":"2017","unstructured":"Feng, W. et al. Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-\u03baB, ERK and JNK signaling pathways. Sci. Rep. 7, 41411. https:\/\/doi.org\/10.1038\/srep41411 (2017).","journal-title":"Sci. Rep."},{"key":"30737_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-051X.2009.01501.x","volume":"37","author":"F Franch-Chillida","year":"2010","unstructured":"Franch-Chillida, F., Nibali, L., Madden, I., Donos, N. & Brett, P. Association between interleukin-6 polymorphisms and periodontitis in Indian non-smokers. J. Clin. Periodontol. 37, 137\u2013144. https:\/\/doi.org\/10.1111\/j.1600-051X.2009.01501.x (2010).","journal-title":"J. Clin. Periodontol"},{"key":"30737_CR34","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1007\/s00784-023-04991-7","volume":"27","author":"B Afacan","year":"2023","unstructured":"Afacan, B., Ilhan, H. A., K\u00f6se, T. & Emingil, G. Gingival crevicular fluid galectin-3 and interleukin-1 beta levels in stage 3 periodontitis with grade B and C. Clin. Oral Investig. 27, 3749\u20133758. https:\/\/doi.org\/10.1007\/s00784-023-04991-7 (2023).","journal-title":"Clin. Oral Investig"},{"key":"30737_CR35","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/jemt.23101","volume":"81","author":"RS de Molon","year":"2018","unstructured":"de Molon, R. S., Park, C. H., Jin, Q., Sugai, J. & Cirelli, J. A. Characterization of ligature-induced experimental periodontitis. Microsc. Res. Tech. 81, 1412\u20131421. https:\/\/doi.org\/10.1002\/jemt.23101 (2018).","journal-title":"Microsc. Res. Tech."},{"key":"30737_CR36","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1097\/TXD.0000000000000653","volume":"3","author":"BH Shin","year":"2017","unstructured":"Shin, B. H., Ge, S., Mirocha, J., Jordan, S. C. & Toyoda, M. Tocilizumab (Anti-IL-6R) suppressed TNF\u03b1 production by human monocytes in an in vitro model of anti-HLA antibody-induced antibody-dependent cellular cytotoxicity. Transpl. Direct. 3, e139. https:\/\/doi.org\/10.1097\/TXD.0000000000000653 (2017).","journal-title":"Transpl. Direct"},{"key":"30737_CR37","doi-asserted-by":"publisher","unstructured":"Chan, A. H. & Schroder, K. Inflammasome signaling and regulation of interleukin-1 family cytokines. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20190314 (2020).","DOI":"10.1084\/jem.20190314"},{"issue":"7","key":"30737_CR38","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3899\/jrheum.121389","volume":"40","author":"K Shimamoto","year":"2013","unstructured":"Shimamoto, K. et al. Serum Interleukin 6 before and after therapy with Tocilizumab is a principal biomarker in patients with rheumatoid arthritis. J. Rheumatol. 40 (7), 1074\u20131081. https:\/\/doi.org\/10.3899\/jrheum.121389 (2013).","journal-title":"J. Rheumatol."},{"key":"30737_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf254","author":"K Suzuki","year":"2025","unstructured":"Suzuki, K. et al. Serum cytokine levels towards precision medicine in still\u2019s disease: a subanalysis of a randomized controlled trial of Tocilizumab. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keaf254 (2025).","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"30737_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41368-019-0068-8","volume":"12","author":"R Cheng","year":"2020","unstructured":"Cheng, R., Wu, Z., Li, M., Shao, M. & Hu, T. Interleukin-1\u03b2 is a potential therapeutic target for periodontitis: a narrative review. Int. J. Oral Sci. 12 (1), 2. https:\/\/doi.org\/10.1038\/s41368-019-0068-8 (2020).","journal-title":"Int. J. Oral Sci."},{"issue":"3","key":"30737_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12026-015-8770-x","volume":"64","author":"T Gaber","year":"2016","unstructured":"Gaber, T. et al. Disentangling the effects of Tocilizumab on neutrophil survival and function. Immunol. Res. 64 (3), 665\u2013676. https:\/\/doi.org\/10.1007\/s12026-015-8770-x (2016).","journal-title":"Immunol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30737-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:25:51Z","timestamp":1767882351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30737-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30737"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30737-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The project of this study was submitted and approved by the Ethics Committee on Teaching and Research in Animals (CEUA) of the Federal University of Rio Grande do Norte (protocol 004\/2021; certificate n\u00ba. 238.004\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}}],"article-number":"1004"}}